Sidley Austin

Asher Rubin

Deals
5
Latest
Jul 2026
Most deals in
Biotech

Firm

Deals by year
Asher Rubin: deals by year0520252026 YTD: 2 M&A2026 YTD: 3 Equity raisings52026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Asher Rubin was named on, most recent first
Jul 2026 Avere Therapeutics –NextCureMergerLegal adviser to NextCureAnnounced–Biotech+1NextCure and Avere Therapeutics merger
Apr 2026 Opus Genetics ––PlacementLegal adviser to the issuerAnnounced5.0Biotech+1Opus Genetics placement
Apr 2026 Obsidian Therapeutics ––PlacementLegal adviser to the issuerCompleted350.0Biotech+2Obsidian Therapeutics placement
Apr 2026 Obsidian Therapeutics –Galera TherapeuticsMergerLegal adviser to Galera TherapeuticsCompleted413.5Biotech+2Galera Therapeutics and Obsidian Therapeutics merger
Feb 2026 Sensei Biotherapeutics ––PlacementLegal adviser to the issuerPending200.0Biotech+2Sensei Biotherapeutics placement

Deals where Asher Rubin is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.